Skip to content

ANODE: Prophylactic antibiotics for the prevention of infection following operative delivery

ANODE: A randomised controlled trial of prophylactic Antibiotics to investigate the prevention of infection following Operative vaginal Delivery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN11166984
Enrollment
3424
Registered
2015-09-23
Start date
2016-02-29
Completion date
Unknown
Last updated
2019-10-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Topic: Reproductive health and childbirth

Interventions

Co-amoxiclav versus placebo, A single intravenous dose (1g amoxycillin/200mg clavulanic acid in 20ml water for injections for active drug, 20ml 0.9% saline for placebo)

Sponsors

University of Oxford
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Female aged 16 years or over 2. Mental capacity (ability to give informed consent) 3. Have had an operative vaginal delivery at at least 36 weeks gestation

Exclusion criteria

Exclusion criteria: Current exclusion criteria as of 04/05/2018: 1. Clinical indication for ongoing antibiotic administration post-delivery e.g. due to confirmed antenatal infection, 3rd or 4th degree tears. Note that receiving antenatal antibiotics e.g. for maternal Group B Streptococcal carriage or prolonged rupture of membranes, is not a reason for exclusion if there is no indication for ongoing antibiotic prescription post-delivery. 2. Known allergy to penicillin or to any of the components of co-amoxiclav, as documented in hospital notes. 3. History of anaphylaxis (a severe hypersensitivity reaction) to another ß-lactam agent (e.g. cephalosporin, carbapenem or monobactam), as documented in hospital notes. Previous exclusion criteria: 1. Clinical indication for ongoing antibiotic administration post-delivery (e.g. due to confirmed antenatal infection, third or fourth degree tears) 2. Known allergy to penicillin (as documented in hospital notes)

Design outcomes

Primary

MeasureTime frame
Confirmed or suspected maternal infection within 6 weeks of delivery.

Secondary

MeasureTime frame
1. Need for additional perineal care/breast feeding determined within 6 weeks of delivery 2. Hospital admissions and diagnoses measured at one-year post delivery 3. Hospital bed stay/hospital and GP visits/wound breakdown/antibiotic side effects determined within 6 weeks of delivery 4. Maternal general health determined within 6 weeks of delivery 5. Relief/dyspareunia/ability to sit comfortably to feed the baby determined within 6 weeks of delivery 6. Perineal wound infection determined within 6 weeks of delivery 7. Cases of surgical site infection (perineal) determined within 6 weeks of delivery 8. Cases of systemic sepsis determined within 6 weeks of delivery

Countries

United Kingdom

Contacts

Public ContactNelly Owino

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 6, 2026